"We Envision Growth Strategies Most Suited
to Your Business"

Drug Delivery Systems Market to Rise at 6.8% CAGR till 2027; Growing Requirement for Precision Drug Delivery for Neurological Disorders to Aid Market Expansion

June 24, 2020 | Healthcare

The global drug delivery systems market size is expected to reach USD 45.20 billion by 2027 on account of rising preference for needle-free drug delivery mechanisms, states Fortune Business Insights™ in its report, titled “Drug Delivery Systems Market Size, Share & Industry Analysis, By Type (Inhalation, Transdermal, Injectables and Others), By Device Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Regional Forecast, 2020-2027”. The report further states that the market value stood at USD 26.08 billion in 2019 and is projected to grow at 6.8% CAGR from 2020 to 2027.


Baxter Optimizes Its COVID-19 Response through Increased Production


In its attempt to optimize its response to the coronavirus pandemic, the US-based healthcare major, Baxter International, announced that it will be maximizing its production capacities to meet the surging need for various medical devices and drug delivery systems in healthcare facilities. Following its announcement in April 2020, Baxter began boosting production of its Spectrum IQ Infusion System and accompanying I.V. administration sets, Mini-Bag Plus drug delivery system, and other injectable drug units to be used in ICUs in hospitals. Moreover, the company is also accessing air freight hauls to transport its products between the US and Europe. Thus, the COVID-19 outbreak has surged the demand for these Systems and market players are looking to capitalize on this once-in-a-lifetime opportunity.


To get a detailed report summary and research scope of this market, click here:


https://www.fortunebusinessinsights.com/drug-delivery-systems-market-103070


Steady Spread of Asthma Worldwide to Stoke Market Growth


Asthma is a chronic respiratory disorder characterized by frequent attacks of wheeziness and breathlessness. Statistics released by the World Health Organization (WHO) reveal that over 339 million people across globe were afflicted by asthma in 2016, with majority of patients being children. Furthermore, the condition killed more than 400,000 and disabled nearly 25 million people worldwide in 2016, the WHO data highlights. Asthmatics heavily rely on different types of inhalers to deliver medication in aerosolized form targeted into their lungs. These devices are portable and extremely convenient to use in any kind of situation and recent advancements have led to the development of inhalers providing metered dosage into the lungs. This bodes well for the Drug Delivery Systems market growth as rising prevalence of asthma is likely to escalate the demand for drug administration systems.


Creation of Delivery Systems for Complex Disorders to Intensify Market Competition


Efficient and effective Drug Delivery Systems can prove vital in treating symptoms and conditions triggered by complex and chronic disorders. Thus, to cater to the patient pool suffering from such conditions, many market players are designing and developing novel delivery systems for the management of these disorders. These efforts are being reflected through increased R&D spending by and strategic partnerships and short-term collaborations among players with diverse capacities.


Industry Development:



  • January 2020: The global drug delivery systems innovator, Aptar Pharma, secured approval from the US Food and Drug Administration (FDA) for its patented Unidose Liquid System. The product is a unique nasal spray engineered for treatment of patients aged six and above suffering from repetitive acute seizures as a result of epilepsy.


List of Companies Covered in this Market Report:



  • Ypsomed (Switzerland)

  • Nemera (France)

  • Gerresheimer AG (Germany)

  • 3M (U.S)

  • Pfizer Inc.(U.S)

  • West Pharmaceutical Services, Inc.(U.S)

  • Medtronic (Ireland)

  • Baxter International Inc. (U.S)

  • BD (Becton, Dickinson and Company)(U.S)


Further Report Findings:



  • In 2019, the transdermal segment held a market share of 12.9% and is expected to grow at a considerable rate as these delivery systems can administer drugs without using needles, which is surging their uptake among patients.

  • Supportive health reimbursement policies will enable North America to dictate this market share during the forecast period. In 2019, the region boasted a market size of USD 10.65 billion.

  • The market in the Middle East & Africa and Latin America enjoys promising prospects on account of growing incidence of chronic obstructive pulmonary disorder (COPD).

  • In Europe, increasing prevalence of chronic diseases and rising demand for these Systems made by European companies in the US will aid the regional market growth.


Table of Segmentation:











































 ATTRIBUTE



  DETAILS



Study Period



  2016-2027



Base Year



  2019



Forecast Period



  2020-2027



Historical Period



  2016-2018



Unit



  Value (USD Billion)



Segmentation



By Type



  • Inhalation

  • Transdermal

  • Injectable

  • Others



By  Device Type



  • Conventional

  • Advanced



By Distribution Channels



  • Hospital Pharmacies

  • Retail Pharmacies

  • Others



By Geography



  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America)

  • The Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



 

Drug Delivery Systems Market
  • PDF
  • 2019
  • 2016-2018
  • 143

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Our Clients

Panasonic
Topcon
Toyota
LG Chem
Facebook
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X